All Activity

A Virginia lawmaker has filed a bill that would legalize and regulate recreational marijuana sales while also increasing the amount of cannabis that adults can possess under the state’s current noncommercial legalization law. The new legislation from Del. Paul Krizek (D) is largely in line with recommendations released last month by the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market, which the lawmaker chaired. Since legalizing cannabis possession and home cultivation in 2021, Virginia lawmakers have worked to establish a commercial marijuana market—only to have those efforts consistently stalled under outgoing Gov. Glenn Youngkin (R), who twice vetoed measures to enact it that were sent to his desk by the legislature. Incoming Gov.-elect Abigail Spanberger (D) supports legalizing adult-use marijuana sales, however. “A consumer should always know what they are buying, and so that means strong labeling,” she said in an interview last month. “That means understanding the strength… If you go and you buy a pack of beer, you know what percentage alcohol that beer is, you know what proof a liquor is, so you have an understanding of what it is that you’re actually purchasing. I think that is extraordinarily important with all marijuana-related products.” Krizek’s new bill, in addition to establishing a system of licensed and regulated businesses to cultivate, process, test and sell cannabis would also increase the amount of marijuana that adults over 21 years of age can legally possess from one ounce to 2.5 ounces. They could also continue to grow up to four cannabis plants at home for personal use. Here are the key details of the new Virginia marijuana bill: Retail sales could begin on November 1, 2026. Adults would be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. The Virginia Cannabis Control Authority would oversee licensing and regulation of the new industry. Its board of directors would have the authority to control possession, sale, transportation, distribution, delivery and testing of marijuana. A tax of up to 11.625 percent would apply to the retail sale of any cannabis product. That would include a state retail and use tax of 1.125 percent on top of a new marijuana-specific tax of 8 percent. Local governments could levy an additional 3.5 percent. Tax revenue would be split between the costs of administering and enforcing the state’s marijuana system, a new Cannabis Equity Reinvestment Fund, pre-kindergarten programs, substance use disorder prevention and treatment programs and public health programs such as awareness campaigns designed to prevent drug-impaired driving and discourage underage consumption. Local governments could not opt out of allowing marijuana businesses to operate in their area. Delivery services would be allowed. Serving sizes would be capped at 10 milligrams THC, with no more than 100 mg THC per package. Existing medical cannabis operators could enter the adult-use market if they pay a $10 million licensing conversion fee. Cannabis businesses would have to establish labor peace agreements with workers. A legislative commission would be directed to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations. It would also investigate the possibility of the Virginia Alcoholic Beverage Control Authority becoming involved in marijuana regulations and enforcement. Meanwhile, Virginia lawmakers have filed other marijuana-related legislation for the 2026 session, including proposals to provide resentencing relief for people convicted of past cannabis crimes and to let terminally ill patients use medical marijuana in hospitals and other healthcare facilities. Separately, the Virginia Department of Labor and Industry recently published a new outlining workplace protections for cannabis consumers. The post New Virginia Bill Would Legalize Recreational Marijuana Sales And Increase Possession Limit appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Republican chair of a key congressional committee is joining with farmers to push for a delay in the planned enactment of a federal law that threatens to recriminalize hemp-derived THC products. “The hemp industry is facing significant challenges and growing uncertainty, and is long past time for Congress to provide farmers and business owners with the clarity they need to succeed,” House Oversight and Government Reform Committee Chairman James Comer (R-KY) said at a press conference on Thursday. “This uncertainty is not abstract. It’s impacting real people, real jobs and real communities all across our country—particularly in rural America.” Comer is calling on colleagues to pass a new bill that was filed in the House this week, the Hemp Planting Predictability Act, that would push back by two years the implementation of legislation President Donald Trump signed last year to reverse the federal legalization of most hemp-derived products that he had approved during his first term in 2018. The renewed ban is currently set to take effect this November. “The crisis that are facing everyone in this room that’s involved in hemp, it’s not a crisis of supply and demand. It’s not a crisis of a trade dispute or terrorists or anything like that. The Senate passed language that was no debate or no discussion that…has the potential to impact hemp in a fatal way.” “The hemp industry’s impact on my home state of Kentucky and nationwide is substantial,” the chairman said. “Hemp supports 320,000 American jobs, generates $28.4 billion in market activity and contributes $1.5 billion in state tax revenue.” If the delay bill were to be enacted, Comer and other stakeholders feel it could give them enough time to convince a majority in Congress that, rather than an outright ban on most consumable hemp products, lawmakers could address concerns about youth access and quality control for intoxicating cannabinoids through a more targeted regulatory approach that includes age-gating and testing requirements. “We’ve got to set up a regulatory framework, and you could stop the wild west out there. And it’s not the growers; fault, it’s not the processors’ fault. People in this room are doing it right,” he told assembled hemp industry participants on Thursday. “But there are some people in America that aren’t doing it right. There are people that are importing counterfeit CBD products from China. There are people that are selling products that aren’t what they say on the label.” “Nobody’s spot checking the labels. That’s what the [Food and Drug Administration] is supposed to do.” Comer said that “nearly every farmer I know who grew hemp last year was a former tobacco farmer.” To that point, Brian Furnish, an eighth-generation farmer from Kentucky who said his family has grown tobacco since the 1700s, spoke about the challenges he and others face in light of uncertainty over federal policy. “If we don’t get a two-year extension, as a farmer I can’t sell my current inventory that I harvested legally and planted legally in 2025. As of right now, [my crop] has lost over $600,000 in price in the last six weeks,” he said. “Our buyers are also telling us that we can’t ship any more biomass to them until they move their inventory. And so it’s a ripple effect through the whole industry, from the people who make the retail product all the way back to the farmer.” Ken Meyer, a farmer from South Dakota, said hemp is a valuable part of his operations. “Farmers grow hemp and rotation with corn and soybeans. It provides another income on the farm, and a valuable one, and it improves their soil,” he said. “Farmers are hurting right now. It is difficult to sell soybeans. Corn prices are low. It is not a time to ban a crop that is so important to the farmers of America.” Abram Phillips, another Kentucky farmer, similarly said that hemp is an “alternative crop that has a higher value that’s good for the soil” and is “an alternative to other extensive and heavier requirement crops.” Comer called on his colleagues to “act swiftly to pass legislation that protects jobs, eliminates bad actors standardizes labeling and requires third party testing.” “These steps are essential to providing certainty for business owners and confidence for consumers,” he said. “Today, American farmers are facing serious, a lot of challenges for farmers all across America, the last thing they need is inaction from Washington that puts a growing, multi-billion dollar industry at risk.” The lawmaker said that if the bill to delay the hemp ban by two years can pass the House, he is “confident we can get it through the Senate.” “I urge both Republicans and Democrats to come together to support this common sense legislation,” he said. “I look forward to continuing to work with my colleagues in Congress and industry stakeholders to get this bill to the president’s desk as quickly as possible.” A recent poll shows that four in five marijuana consumers say they oppose the recriminalization of hemp THC products under the spending bill Trump signed in November. However, it should be noted that that poll was conducted weeks before he issued a cannabis rescheduling order and took steps to protect access to full-spectrum CBD. Trump signed an executive order last month directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). Part of that announcement also hold implications for the forthcoming hemp law. The president’s order also urged Congress to examine updating the definition of hemp to ensure that full-spectrum CBD is accessible to patients. A further redefinition of hemp would be part of a novel proposal to allow Medicare recipients to access non-intoxicating CBD that’d be covered under the federal health care plan. To effectuate that, the Centers for Medicare & Medicaid Services (CMS) will be announcing “a model that will allow a number of CMS beneficiaries to benefit from receiving CBD under doctor recommendation at no cost,” a White House official said during a briefing that Marijuana Moment first reported leaked details from ahead of the signing event. Trump seemed endorse a more flexible CBD policy last summer when he shared a video calling for that specific reform while promoting the health benefits of cannabidiol, particularly for seniors. Meanwhile, a separate recently filed Republican-led congressional bill would stop the implementation of the hemp ban under the enacted appropriations legislation. Hemp businesses and industry groups have warned about the potential ramifications of the ban, but despite his support for states’ rights for cannabis and a recent social media post touting the benefits of CBD, Trump signed the underlying spending measure into law without acknowledging the hemp provisions. GOP political operative Roger Stone said recently that Trump was effectively “forced” by Republican lawmakers to sign the spending bill with the hemp THC ban language. However, a White House spokesperson said prior to the bill signing that Trump specifically supported the prohibition language. The Democratic governor of Kentucky said that the hemp industry is an “important” part of the economy that deserves to be regulated at the state level—rather than federally prohibited, as Congress has moved to do. Also, a leading veterans organization is warning congressional leaders that the newly approved blanket ban on consumable hemp products could inadvertently “slam the door shut” on critical research. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Since 2018, cannabis products have been considered legal hemp if they contain less than 0.3 percent delta-9 THC on a dry weight basis. The newly enacted legislation specifies that, within one year of enactment, the weight will apply to total THC—including delta-8 and other isomers. It will also include “any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).” The new definition of legal hemp will additionally ban “any intermediate hemp-derived cannabinoid products which are marketed or sold as a final product or directly to an end consumer for personal or household use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or not capable of being naturally produced by it. Legal hemp products will be limited to a total of 0.4 milligrams per container of total THC or any other cannabinoids with similar effects. Within 90 days of the bill’s enactment, the Food and Drug Administration (FDA) and other agencies will need to publish list of “all cannabinoids known to FDA to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature,” “all tetrahydrocannabinol class cannabinoids known to the agency to be naturally occurring in the plant” and “all other known cannabinoids with similar effects to, or marketed to have similar effects to, tetrahyrocannabinol class cannabinoids.” The language slightly differs from provisions included in legislation that had previously advanced out of the House and Senate Appropriations panels, which would have banned products containing any “quantifiable” amount of THC, to be determined by the HHS secretary and secretary of agriculture. The post Key GOP Congressional Committee Chairman Pushes To Delay Hemp THC Ban, Saying It Will Hurt Farmers appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

That appears to be excellent however i am still not too sure that I like it. At any rate will look far more into it and decide personally! 강남쩜오

Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! situs slot Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. situs slot

All your hard work is much appreciated. Nobody can stop to admire you. Lots of appreciation. 일산룸

The U.S. House of Representatives has passed a spending bill that contains a provision to continue blocking Washington, D.C. from legalizing recreational marijuana sales while also warning local officials about approving cannabis dispensaries near schools. The appropriations legislation covering Financial Services and General Government (FSGG) as well as National Security, Department of State, and Related Programs Appropriations Act for Fiscal Year 2026, was approved on the floor in a vote of 341-79 on Wednesday. A report attached to the legislation also contains a section directing federal officials to submit a report on Chinese-linked drug syndicates that operate illicit cannabis grows. The District has long been barred from allowing regulated adult-use marijuana sales under a spending bill rider led by Rep. Andy Harris (R-MD), despite voters approving legalization of possession and personal cultivation in 2014. Leaders of the House and Senate Appropriations Committees who negotiated the legislation ahead of its release on Sunday evidently didn’t see reason to shift away from that policy. Here’s the text of the D.C. sales rider: “SEC. 809. (a) None of the Federal funds contained in this Act may be used to enact or carry out any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance under the Controlled Substances Act (21 U.S.C. 801 et seq.) or any tetrahydrocannabinols derivative. (b) No funds available for obligation or expenditure by the District of Columbia government under any authority may be used to enact any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance under the Controlled Substances Act (21 U.S.C. 801 et seq.) or any tetrahydrocannabinols derivative for recreational purposes.” The language may ultimately be rendered moot, however, if the Trump administration moves forward with an order from the president to expeditiously reclassify cannabis as a Schedule III substance under the Controlled Substances Act (CSA). In a report published in 2024, the Congressional Research Service (CRS) said that while federal cannabis prohibition would still be the law of the land even if it’s rescheduled, the reform “would permit the District government, as a matter of local law, to authorize the commercial sale of recreational marijuana, establish market regulations, and levy marijuana taxes, among other policy options.” There is a complication, however, because the congressional rider also stipulates that the District of Columbia can’t use funds to legalize or reduce penalties for “any tetrahydrocannabinols derivative.” But that term isn’t clearly defined in the rider or anywhere else in federal law. Meanwhile, the FSGG report attached to the new spending bill also reminds D.C. officials that cannabis remains federally prohibited, and there are enhanced penalties for manufacturing or distributing marijuana within 1,000 feet of various public and private entities like schools and playgrounds. Here’s that D.C.-specific language: “Marijuana Dispensary Proximity to Schools.-The agreement reminds the District of Columbia that the distribution, manufacturing, and sale of marijuana remains illegal under Federal law, which includes enhanced penalties for such distribution within one thousand feet of a public or private elementary, vocational, or secondary school or public or private college, junior college, or university, or a playground, among other real property where children frequent.” Another section of the report for the National Security and State bill concerns illegal drug syndicates based out of the People’s Republic of China (PRC). Here’s what that section says: “PRC-linked Criminal Drug Syndicates.-Not later than 45 days after the date of enactment of the Act, the Secretary of State, in consultation with the heads of other relevant Federal agencies, shall submit a report to the appropriate congressional committees regarding PRC-linked criminal syndicates or nationals who may be directly or indirectly involved in illegal drug and money laundering operations in the United States, including in Maine, California, and Oregon. The information should include, as relevant, information on the involvement of officials of the Government of the PRC and PRC-linked syndicates operating in Southeast Asia.” While the provision doesn’t mention marijuana specifically, it seems intended to target illicit Chinese cannabis operators, which were also the focus of a House subcommittee hearing last September. Much of the talk about the issue has centered around Maine, California and Oregon, as referenced in the report section. The appropriations deal was unveiled just days after the House passed a separate spending package that would continue protecting state medical marijuana programs from federal intervention—while excluding a provision that previously advanced to block the Justice Department from rescheduling cannabis. That proposal now heads to the Senate for consideration. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — GOP senators have separately tried to block the administration from rescheduling cannabis as part of a standalone bill filed in 2023, but that proposal did not receive a hearing or vote. Meanwhile, last week, the Drug Enforcement Administration (DEA) said the marijuana rescheduling appeal process “remains pending” despite President Donald Trump’s recent executive order directing the attorney general to finalize the process of moving cannabis to Schedule III. Advocates may welcome the exclusion of the rescheduling provision and inclusion of medical marijuana protections in the CJS bill, but many cannabis stakeholders have protested Trump’s signing of a separate appropriations measure in November that includes provisions to ban most consumable hemp products. The post House Passes Bill To Keep Blocking Washington, D.C. From Legalizing Marijuana Sales appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

You there, this is really good post here. Thanks for taking the time to post such valuable information. Quality content is what always gets the visitors coming. slot online gacor

If you are looking for more information about flat rate locksmith Las Vegas check that right away. 강남쩜오

Two Republican senators have filed an amendment that seeks to block the Justice Department from carrying out President Donald Trump’s executive order to quickly finish the process of reclassifying marijuana under federal law. Sens. Ted Budd (R-NC) and James Lankford (R-OK) are seeking to attach the proposal to Fiscal Year 2026 funding legislation for DOJ that is on the Senate floor this week. “None of the funds made available by this division may be used to transfer marijuana, as defined in section 102 of the Controlled Substances Act (21 U.S.C. 802), from schedule I of section 202(c) of that Act (21 U.S.C. 812(c)) to another schedule of that section,” the amendment says. Similar cannabis prohibition language had advanced through the House Appropriations Committee before being removed from a bicameral spending legislation deal negotiated by leaders from both chambers. That legislation passed the House last week. Now, the two GOP senators are seeking to reinsert the prohibition on marijuana rescheduling into the bill before it clears their chamber. It is not clear if the amendment will receive a debate or vote on the Senate floor—but if it is enacted into law, DOJ would not be able to reschedule marijuana to Schedule III in line with the pending administrative proposal. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Last month, Budd led a letter joined by more than 20 other senators, including Lankford, that had urged Trump to reject the marijuana rescheduling proposal that was initiated during the Biden administration—arguing that it would “undermine your strong efforts to Make America Great Again and to usher in America’s next economic Golden Age.” House members sent a separate letter to the president saying that “rescheduling marijuana will not make America great.” “You have always been a role model for America’s youth, telling young people for years that they should never do drugs,” the House members wrote. “We hope that you consider the harms of marijuana rescheduling and continue sending that strong message of hope to the next generation.” Trump ultimately dismissed the concerns of GOP lawmakers who oppose marijuana rescheduling when asked about the letters, pointing out that an overwhelming majority of Americans support the reform and that cannabis can help people—including his personal friends—who are suffering from serious health issues. GOP senators previously tried to block the administration from rescheduling cannabis as part of a standalone bill filed in 2023, but that proposal did not receive a hearing or vote. Separately, a coalition of Republican state attorneys general criticized Trump’s rescheduling decision, saying cannabis is “properly” classified as a Schedule I drug with no accepted medical use and a high potential for abuse. Meanwhile, last week the Drug Enforcement Administration (DEA) said a marijuana rescheduling appeal process “remains pending” despite Trump’s executive order. The post GOP Senators File Amendment To Block Trump From Rescheduling Marijuana appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Rand Paul & Joe Rogan talk hemp; NJ interstate marijuana commerce bill; NH psilocybin hearing; Poll: Canadian legalization support grows Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Sen. Rand Paul (R-KY) surprised Joe Rogan by telling him that the marijuana and alcohol industries jointly pushed to enact a recent law federally recriminalizing hemp THC products. “It was a little bit of the alcohol lobby and the cannabis lobby. The cannabis people hate the hemp people.” Ohio Attorney General Dave Yost (R) rejected a referendum petition to block parts of a restrictive marijuana and hemp law from going into effect, saying its summary is “misleading” and must be revised in order to proceed. New Jersey’s Senate president filed a bill to legalize interstate cannabis commerce, subject to certain triggers and restrictions. The New Hampshire House Health, Human Services and Elderly Affairs Committee held a hearing on two psilocybin bills that would legalize the regulated use of the psychedelic for medical purposes. A new poll of Canadian adults shows that support for marijuana being legal is increasing over time, with two-thirds of respondents now saying they back the reform—though relatively few respondents back legalizing other drugs. / FEDERAL Rep. Mike Rogers (R-MI) claimed that drug enforcement at the border will save people from smoking fentanyl-laced marijuana joints. Rep. Eleanor Holmes Norton (D-DC) said she is disappointed that a funding bill advancing in Congress would continue blocking Washington, D.C. from legalizing recreational marijuana sales. The Senate bill to regulate hemp products got one new cosponsor for a total of two. / STATES Pennsylvania’s treasurer, who is running for governor, said she doesn’t believe there is “as much revenue in the legalization of marijuana as you would think.” A new member of the New Jersey Cannabis Regulatory Commission began his term, and regulators took action on marijuana business licensing. Massachusetts regulators are recognizing an additional form of ID for marijuana purchases. Maryland regulators fined a marijuana business for allegedly violating tracking and inventory rules. Michigan regulators published a monthly report on disciplinary actions taken against marijuana businesses. California regulators sent updates about various cannabis issues. The Nevada Cannabis Compliance Board will meet on Thursday. The Rhode Island Cannabis Control Commission will meet on Friday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The San Diego County, California Board of Supervisors is considering changes to cannabis business rules. West Sacramento, California officials are moving to scrap the city’s cannabis equity program. The Oakland, California Cannabis Regulatory Commission will meet on Thursday. / INTERNATIONAL Kenya’s High Court rejected a request to stop marijuana possession arrests of Rastafarians pending a determination on a petition to decriminalize spiritual cannabis use. / SCIENCE & HEALTH A study found that “CBD protects human skin from [particulate matter]-induced molecular damage and supports its potential as a functional bioactive ingredient for anti-pollution applications.” A study found that”CBG has been demonstrated to exert significant anti-inflammatory effects via modulation of key inflammatory mediators and signaling pathways in both in vivo and in vitro models.” A study found that “an acute dose of CBD (300 mg) taken 2 h before a 2-mile run may potentially benefit runners in shorter distance competitions by increasing calm and relaxed feelings and reducing perceived effort at the halfway point without impairing performance or increasing gastrointestinal upset.” / ADVOCACY, OPINION & ANALYSIS Wine & Spirits Wholesalers of America is supporting congressional legislation to delay implementation of the federal recriminalization of hemp THC products. / BUSINESS Circle K is launching hemp THC beverage sales in Texas. Aurora Cannabis Inc. said it is making “significant progress” in powdery mildew resistance research. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Ohio AG rejects cannabis referendum ballot petition (Newsletter: January 15, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Featuring voices such as Samantha Montanaro and Lisa Snyder adds depth and purpose to the gathering beyond just networking. It’s inspiring to see local communities in Oregon using their platforms to drive positive change. In a similar way, Veck IO shows how focused communities and thoughtful engagement can create impact that goes beyond the surface.

That’s an impressive track record, Erica. It’s great to see someone who’s so active in community engagement and clearly connected across networks. Wishing you the best in your Centennial School Board race and continued impact in Oregon. If you’re curious about community-friendly games during downtime, I’ve enjoyed checking out Retro Bowl for quick, light-hearted play sessions.

That’s such a fitting pick for Member of the Month, Erica brings real energy and kindness to every session. Her thoughtful guidance and steady positivity inspire others to show up authentically. If you’re curious about her projects, I’d love to hear what everyone admires most about her approach. Also, for fans of collaborative spaces, Fnaf

Really I enjoy your site with effective and useful information. It is included very nice post with a lot of our resources.thanks for share. i enjoy this post. koitoto Thank you because you have been willing to share information with us. we will always appreciate all you have done here because I know you are very concerned with our. togel online Very informative post! There is a lot of information here that can help any business get started with a successful social networking campaign. situs toto Nice post! This is a very nice blog that I will definitively come back to more times this year! Thanks for informative post. togel 4d

This is so inspiring! Bianca Snyder is doing crucial work showing that responsible cannabis use is compatible with motherhood. The normalization effort starts with visibility, especially on social platforms. For anyone running a business with a massive social media presence, remembering to *resize image* assets for optimal viewing across platforms is key to maximizing that impact. Keep changing the narrative, Canna Moms!

New Hampshire lawmakers on Wednesday took up a pair of bipartisan bills to legalize the regulated use of psilocybin for medical purposes. At a hearing before the House Health, Human Services and Elderly Affairs Committee, members heard public testimony on the proposals: HB 1809 from Rep. Buzz Scherr (D) and HB 1796 from Rep. Michael Moffett (R). Both measures seek to create a regulatory pathway for patients with certain conditions to access the psychedelic for therapeutic use through a program overseen by the state Department of Health and Human Services (DHHS). But Moffett’s legislation is more prescriptive about the proposed regulatory framework. “I am an unlikely prime sponsor for a measure such as this,” Moffett told fellow lawmakers at the hearing, saying he’s “always been very wary and skeptical of” psychedelics and has “always been a hard no on marijuana for many reasons, to include the fact that I was constantly drug tested myself for many years in the Marine Corps, where I developed a zero tolerance for illegal drug use.” He said that he changed his mid after seeing a presentation on psychedelic therapies at a national veterans conference last summer, where he learned that “a psilocybin treatment option could have value to almost anyone, beyond military people or former military people.” Scherr, for his part, said there’s a “substantial amount of research going on currently about the therapeutic uses of psilocybin.” “The research in terms of it helping with those who have treatment-resistant depression is pretty significant at this point,” he said. “Research in terms of broader use for those suffering from other forms of PTSD is developing. Research for use with people who have certain forms of substance abuse is also developing.” Jenny O’Higgins of the state Department of Health and Human Services said officials have some concerns around the lack of appropriated funds in Moffett’s legislation, saying the department would “not be able to absorb” the program under its current budget. A representative of the prohibitionist organization Smart Approaches to Marijuana’s New Hampshire affiliate testified against the proposals, saying that psilocybin is a federally illegal Schedule I drug. She also argued that there is insufficient evidence to support the psychedelic’s therapeutic potential. Here are the key provisions of HB 1809: DHHS would be responsible for approving licensed medical professional to serve as providers of psilocybin for qualifying patients. In order to qualify for the program, patients would need to be diagnosed with treatment-resistant depression, post-traumatic stress disorder (PTSD), substance use disorder or another condition authorized by an advisory board and DHHS. The legislation specifically stipulates that only natural psilocybin could be administered, excluding synthetic versions of the psychedelic. Providers would also need to be approved by the department to grow and harvest their own psilocybin products. The process for treating qualifying patients with the psychedelic would need to involve a preparation session, administration session and integration session. A Medical Psilocybin Advisory Board would be established, comprised of a representative of DHHS, a qualifying patient, a veterans advocate and eight medical professionals. Those medical experts would need to include a psychedelics researcher, two regulators overseeing existing medical psilocybin programs and specialists in the treatment of addiction, palliative care, veterans’ affairs, naturopathy, nursing and mental health counseling. The board would be tasked with analyzing data on patient outcomes from DHHS, consider adding qualifying conditions for participation in the program and determine whether the law should be expanded. The program would only be implemented if the advisory board, within two years of the bill’s enactment, notifies lawmakers, regulators and the governor that it can be effectively administered. “The medical community has always recognized that patients exist with serious conditions that are very resistant to effective treatment,” a statement of purpose for the measure says. “Recently, research has begun to show that certain of those patients have had positive results with the closely supervised use of psilocybin for treatment.” “Patients with significant post-traumatic stress disorder, with treatment-resistant clinical depression, and with serious substance use disorder have been shown to benefit from the controlled, therapeutic use of psilocybin in a supervised setting,” it says. “The purpose of this act is to create a carefully monitored and closely supervised setting in which an approved medical provider can treat a carefully chosen patient with appropriate doses of psilocybin which that same provider has produced for a medical intervention.” Here are the main details of HB 1796: The bill would permit the regulated use of psilocybin in a medically supervised setting, with DHHS responsible for overseeing the program. To qualify for psilocybin treatment, a patient 21 or older would need to be diagnosed with treatment-resistant depression, PTSD, substance misuse disorder, a terminal illness requiring end-of-life care or any other condition authorized by DHHS. A Psilocybin Licensing Board under the department would be tasked with issuing licenses for independent medical psilocybin providers, therapy providers, cultivators and testing laboratories. There would be specific guidelines for facilities where the psychedelic could be administered, including security requirements and other safety protocols such as ensuring there are rescue medications on site if a patient experiences an adverse event. The legislation would also establish a Therapeutic Psilocybin Treatment Fund, which would be funded by revenue from licensing taxes and fees. The fund would go toward studies into the possibility of expanding the program to include additional psychedelics in the program. The law if enacted would take effect beginning in January 1, 2027. “The purpose of the Therapeutic Psilocybin Act is to allow the beneficial use of psilocybin in a regulated system for alleviating qualified medical conditions,” the bill’s statement of purpose says. The prospects of either bill advancing this session remain unclear, but lawmakers have been increasingly active in pursuing psychedelics reform in recent years. Last June, the New Hampshire Senate voted to scrap compromise legislation that would have lowered the state’s criminal penalty for first-time psilocybin possession while also creating mandatory minimum sentences around fentanyl. As originally introduced, the legislation would have completely removed penalties around obtaining, purchasing, transporting, possessing or using psilocybin, effectively legalizing it on a noncommercial basis. However a House committee amended the bill before unanimously advancing it last March. Meanwhile in New Hampshire, the House last week approved a bill to legalize marijuana in the state—though its chances of passage in the Senate remain dubious, and the governor has expressed clear opposition to the reform. Also last week, the chamber passed a proposal to allow medical cannabis dispensaries to become for-profit businesses. The legalization bill, sponsored by Rep. Jared Sullivan (D), is one of several cannabis proposals filed for the 2026 session, including legislation from Rep. Jonah Wheeler (D) that seeks to put a constitutional amendment on the state ballot that would let voters decide if they want to legalize marijuana for adults 21 and older, allowing them to “possess a modest amount of cannabis for their personal use.” Gov. Kelly Ayotte (R) has already threatened to veto any legalization bill that reaches her desk, though the constitutional amendment proposal would not require gubernatorial action. The governor said in August that her position on the reform would not change even if the federal government moved forward with rescheduling the plant. Since then, President Donald Trump has directed the attorney general to finalize the process of moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). At a committee meeting last year, Sullivan ultimately made a persuasive argument for advancing his legalization bill, pointing out that the House has repeatedly passed similar legislation and that the chamber should stand its ground, forcing the Senate and governor to again go on record with their opposition to a policy popular among voters. “We know where it’s going to go. Let’s send a virtue signal,” Sullivan said. “Let them be the ones that are pissing off voters who care about this.” Meanwhile, the House also approved a bill last week from Rep. Wendy Thomas (D) that would allow medical marijuana dispensaries (known as “alternative treatment centers,” or ATCs, in the state) to convert their dispensary licenses to become for-profit entities. HB 54, which passed on the consent calendar with other legislation, previously advanced unanimously out of the House Finance Committee. Part of the motivation behind the legislation is the fact that medical marijuana dispensaries don’t qualify for federal non-profit status. But in the state, they’re considered non-profit organizations, which has resulted in disproportionately increased operating costs. Other bills filed for 2026 include two proposals to protect the gun rights of medical cannabis patients. There are also a few pieces of legislation aimed at regulating hemp sales—an issue that’s receiving heightened attention given that Congress passed, and Trump signed, an appropriations bill that would effectively re-criminalize most consumable hemp products. Meanwhile, after the House added provisions to a Senate-passed bill last year that would allow medical marijuana patients to grow cannabis at home, those measures were stripped in conference. Image courtesy of CostaPPR. The post New Hampshire Lawmakers Take Up Bipartisan Bills To Legalize Psilocybin For Medical Use appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

New Jersey’s Senate president has filed a bill that would allow marijuana companies to engage in interstate commerce. Under the proposal from Sen. Nicholas Scutari (D), the governor would be empowered to “enter into an agreement with another state or states authorizing medicinal or personal-use commercial cannabis activity, or both, between entities licensed under the laws of the contracting state and entities operating with a State license” in New Jersey. However, the reform would only take effect under certain conditions, such as if federal law changed to explicitly allow interstate marijuana commerce, the U.S. Department of Justice issued a memo saying it would tolerate the activity or if Congress passed legislation blocking officials from enforcing the prohibition on cannabis sales between states. Alternatively, the policy could move forward if the state attorney general issued an opinion determining that the law’s implementation “will not result in significant legal risk to this State based on review of federal judicial decisions and administrative action.” Cannabis products brought into the state from another market under the bill’s framework would need to be subject rules equivalent to New Jersey’s regulations, including with respect to testing, packaging, labeling, marketing, tracking and quality assurance. Scutari has introduced interstate cannabis commerce legislation in previous sessions, but none of those proposals were enacted into law. Several other states already have interstate marijuana commerce laws in place. California Gov. Gavin Newsom (D), for example, signed a bill in 2022 that empowers him to enter into interstate cannabis commerce agreements with other legal states, but that power is incumbent upon federal guidance or an assessment from the state attorney general that sanctioned such activity. Following a review of the policy proposal, however, California Attorney General Rob Bonta’s (D) office ultimately determined in 2023 that the state could put itself and its employees at “significant legal risk” of federal enforcement action if it were to authorize interstate marijuana commerce. Oregon and Washington State have also passed laws allowing officials to enter into cross-border cannabis trade agreements with other states, although those state laws both require some form of federal reform or guidance to proceed. Meanwhile, lawmakers in Congress have filed legislation intended to help small marijuana growers compete against large corporations in the event of federal legalization—proposing to give them the ability to ship and sell cannabis products directly to consumers within and across state lines via the U.S. Postal Service (USPS) and commercial carriers. Back in New Jersey, lawmakers this week sent Gov. Phil Murphy (D) a bill to create a psilocybin therapy pilot program and allocate $6 million in funding to support the effort. In other New Jersey drug policy news, voters in November elected U.S. Rep. Mikie Sherrill (D-NJ) to serve as the state’s next governor, and there’s now a decidedly clearer path to advancing a marijuana reform long awaited by consumers and advocates in the Garden State: A home grow option. Meanwhile, as New Jersey’s first marijuana consumption lounges opened up over the summer, regulators shared information about where to find the sites and offering tips about how to responsibly use cannabis at the licensed businesses—including classic stoner cultural customs like “puff, puff, pass.” New Jersey officials have also completed the curriculum of a no-cost marijuana training academy that’s meant to support entrepreneurs interested in entering the cannabis industry. The post New Jersey Marijuana Businesses Could Engage In Interstate Commerce Under Senate President’s New Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Ohio’s attorney general has rejected activists’ referendum petition to block parts of a restrictive marijuana and hemp law from going into effect, saying its summary is “misleading” and must be revised in order to proceed. “Upon review of the summary, we identified omissions and misstatements that, as a whole, would mislead a potential signer as to the scope and effect of S.B. 56,” Attorney General Dave Yost (R) wrote in a letter to the petitioners on Tuesday. The referendum, led by Ohioans for Cannabis Choice, seeks to repeal key components of a bill the governor recently signed to scale back the state’s voter-approved marijuana law and ban the sale of consumable hemp products outside of licensed cannabis dispensaries. The group submitted an initial batch of 1,000 signatures to get the referendum process started last month. Yost said that several aspects of the petition summary are misleading. For example it contains “two very similar descriptions” of the definition of hemp, the attorney general said, meaning that “a potential signer would likely be misled as to the character and import of this definition.” The submission also “inaccurately” states that SB 56 “permits delivery of adult use cannabis,” Yost said. “Nowhere in the bill is the division of cannabis control authorized to adopt rules on the delivery of adult-use cannabis.” The summary additionally “inaccurately states that felony offenses are disqualifying for cannabis-related licensure,” the letter claims, pointing out that Gov. Mike DeWine (R) vetoed that provision and it is thus not part of the enacted law. “The summary inaccurately states S.B. 56 repealed a prohibition of license holders offering gifts, samples or other free or discounted adult-use marijuana products,” Yost added. “This is false. First, no such prohibition was repealed by S.B. 56. Instead, the bill directs the division of cannabis control to ‘establish standards prohibiting the use of gifts, samples, or other free or discounted goods or services to induce or reward a license holder for business or referrals.'” Also, the petition “misleads the reader into believing that S.B. 56 gives local governments the authority to pass ordinances that prohibit or limit the rights of license holders and/or prohibit other activities that are permitted under statewide cannabis control laws,” the attorney general’s letter says. Finally, Yost said that the petition summary “incorrectly states” that the bill authorizes local governments to levy excise taxes on recreational cannabis sales. “The above instances are just a few examples of the summary’s omissions and misstatements, and further review will be undertaken should the matter be resubmitted,” Yost told organizers in the letter. Dennis Willard, spokesperson for Ohioans for Cannabis Choice, said the campaign will “fix the language, collect an additional 1,000 signatures, and not slow down.” “Voters this November will have the opportunity to say no to S.B. 56, no to government overreach, no to closing 6,000 businesses and abandoning thousands of Ohio workers, and no to defying the will of Ohioans who overwhelmingly supported legalizing cannabis in 2023,” he said. DeWine’s office and a senator who led the charge to pass SB 56 have criticized the cannabis referendum campaign. If and when the resubmitted petition is approved for broader circulation, the campaign will need to collect a total of about 250,000 signatures to make the ballot. In general, the proposed referendum would repeal the first three core sections of SB 56, a controversial bill that DeWine signed into law last month that he says is intended to crack down on the unregulated intoxicating hemp market. But the legislation would do more than restrict the sale of cannabinoid products to dispensaries. The law also recriminalizes certain marijuana activity that was legalized under the ballot initiative voters approved in 2023, and it’d additionally remove anti-discrimination protections for cannabis consumers that were enacted under that law. The governor additionally used his line-item veto powers to cancel a section of the bill that would have delayed the implementation of the ban on hemp beverages. Advocates and stakeholders strongly protested the now-enacted legislation, arguing that it undermines the will of voters who approved cannabis legalization and would effectively eradicate the state’s hemp industry, as there are low expectations that adults will opt for hemp-based products over marijuana when they visit a dispensary. The pushback inspired the newly filed referendum—but the path to successfully blocking the law is narrow. If activists reach the signature threshold by the deadline, which coincides with the same day the restrictive law is to take effect, SB 56 would not be implemented until voters got a chance to decide on the issue at the ballot. A summary of the submitted referendum states that “Sections 1, 2, and 3 of Am. Sub. S. B. No. 56 enact new provisions and amend and repeal existing provisions of the Ohio Revised Code that relate to the regulation, criminalization, and taxation of cannabis products, such as the sale, use, possession, cultivation, license, classification, transport, and manufacture of marijuana and certain hemp products.” “If a majority of the voters vote to not approve Sections 1, 2, and 3 of the Act, then the enacted changes will not take effect and the prior version of the affected laws will remain in effect,” it says. Advocates have flagged a series of concerns with the law, pointing out, for example, that it would eliminate language in statute providing anti-discrimination protections for people who lawfully use cannabis. That includes protections meant to prevent adverse actions in the context of child custody rights, the ability to qualify for organ transplants and professional licensing. It would also recriminalize possessing marijuana from any source that isn’t a state-licensed dispensary in Ohio or from a legal homegrow. As such, people could be charged with a crime for carrying cannabis they bought at a legal retailer in neighboring Michigan. Additionally, it would ban smoking cannabis at outdoor public locations such as bar patios—and it would allow landlords to prohibit vaping marijuana at rented homes. Violating that latter policy, even if it involves vaping in a person’s own backyard at a rental home, would constitute a misdemeanor offense. The legislation would also replace what had been a proposed regulatory framework for intoxicating hemp that the House had approved with a broad prohibition on sales outside marijuana dispensaries following a recent federal move to recriminalize such products. Under the law, hemp items with more than 0.4 mg of total THC per container, or those containing synthetic cannabinoids, could no longer be sold outside of a licensed marijuana dispensary setting. That would align with a recently enacted federal hemp law included in an appropriations package signed by President Donald Trump. The federal law imposing a ban on most consumable hemp products has a one-year implementation window, however, and it appears the Ohio legislation would take effect sooner. As passed by the legislature, a temporary regulatory program for hemp beverages would have stayed in place in Ohio until December 31, 2026, but that provision was vetoed by the governor. The law also includes language stipulating that, if the federal government moves to legalize hemp with higher THC content, it’s the intent of the Ohio legislature to review that policy change and consider potential state-level reforms to regulate such products. The bill signing came months after DeWine issued emergency rules prohibiting the sale of intoxicating hemp products for 90 days, with instructions to the legislature to consider permanent regulations. A county judge has enjoined the state from enforcing that policy in response to a legal challenge. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, in September, the Ohio Department of Cannabis Control (DCC) filed proposed rules to build upon the state’s marijuana legalization law, laying out plans to update regulations on labeling and packaging requirements. Ohio retailers sold more than $1 billion worth of legal marijuana products in 2025, according to data from the state Department of Commerce (DOC). In March, a survey of 38 municipalities by the Ohio State University’s (OSU) Moritz College of Law found that local leaders were “unequivocally opposed” to earlier proposals that would have stripped the planned funding. Meanwhile in Ohio, adults as of June are able to buy more than double the amount of marijuana than they were under previous limits, with state officials determining that the market can sustainably supply both medical cannabis patients and adult consumers. The governor in March separately announced his desire to reallocate marijuana tax revenue to support police training, local jails and behavioral health services. He said funding police training was a top priority, even if that wasn’t included in what voters passed in 2023. The post Ohio Attorney General Rejects Cannabis Referendum Petition, Saying It’s ‘Misleading’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

SteamUnlocked is the official site for downloading free pre-installed PC games. Explore clean, fast, and verified downloads across every genre. https://steamunlocked.org/

Totals Bets on the total number of goals, points, or sets. The bettor must correctly guess whether the actual result will be over or under a specified number. 1xbet casino promo code hong kong

It’s been eight years since Canada legalized marijuana nationwide, and a new poll shows that support for the reform is increasing over time. Relatively few Canadians want to legalize other drugs, however. Roughly two-thirds of Canadian adults (65 percent) now say they agree with cannabis being legal, according to the survey from Research Co. That’s up three percentage points since the firm last polled on the topic in 2024. Just 29 percent of respondents disagree with marijuana legalization, and 6 percent say they’re not sure how they feel about the reform. The survey, which was conducted from December 7-9, 2025, and involved online interviews with a representative sample of 1,002 adults in Canada, shows that there is majority support for cannabis being legal in each geographic and racial demographic breakdown reported by the pollster. Thirty-six percent of respondents say they consumed marijuana prior to it becoming legal, 15 percent used it only after legalization and 49 percent say they have never tried it. Among those who have used cannabis since it was legalized in October 2018, 48 percent say all of it was acquired at a licensed retailer, 17 percent say most it was from a legal shop, 13 percent got some of it from a licensed store and 16 percent got all of their cannabis outside the legal retail system. Despite growing majority support for legal marijuana, only a minority of Canadians support legalizing other drugs such as MDMA (14 percent), powder cocaine (12 percent), crack cocaine (10 percent), meth (10 percent), heroin (9 percent) and fentanyl (9 percent), the poll shows. When asked whether companies should be able to drug test employees for marijuana, 34 percent said they definitely should, 30 percent said they probably should, 14 percent said probably not and 13 percent said definitely not. “There is no political divide when Canadians are asked about drug tests for employees,” Mario Canseco, President of Research Co., said in a press release. “Majorities of respondents who voted for the Conservatives (69%), the Liberals (68%) or the New Democrats (58%) in 2025 think the measure is justified now that marijuana is legal.” The poll has a 3.1 percentage point margin of error. A survey released last year also showed that a majority of Canadians feel the marijuana sector that’s emerged since cannabis was legalized nationwide is an “important contributor” to the country’s economy. Canadians seem to recognize the value of the cannabis industry to the country’s overall financial health, with 59 percent describing the sector as a valuable component of the economy. That includes 69 percent of recent Liberal voters and 58 percent of recent Conservative voters. When the research firm and Organigram last asked Canadians that question last April, 57 percent agreed about the importance of the marijuana market relative to the national economy, so this represents a slight increase. Observers have also been watching how broader adult-use legalization impacts medical marijuana in Canada, noting, for example, patient enrollment rates declining after legalization was enacted but before retailers opened for business. A study released last year, meanwhile, found similar marijuana use rates and support for legalization in both the U.S. and Canada despite the countries’ different national approaches to regulating the drug. Another report last year found that marijuana legalization was “associated with a decline in beer sales,” suggesting a substitution effect where consumers shift from one product to the other. Meanwhile, a separate survey out of Canada that was financially supported by the government recently found that youth marijuana use rates have declined after the country legalized cannabis—contradicting concerns voiced by prohibitionists. A separate Canadian government report found that daily or near-daily use rates by both adults and youth have held steady over the last six years after the country enacted legalization. The post Canadian Support For Marijuana Legalization Is Increasing, New Poll Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

It is my first visit to your blog, and I am very impressed with the articles that you serve. Give adequate knowledge for me. Thank you for sharing useful material. I will be back for the more great post. 강남쩜오

Choosing the right events to bet on involves focusing on popular sports and significant matches. To bet wisely, a player should understand the rules of the sport and have basic knowledge of team statistics. It’s also important to: promo code 1xbet ethiopia

Great post, you have pointed out some excellent points, I as well believe this is a very superb website. 강남쩜오

Very useful — I appreciated screenshots of active marketplace trades. A healthy market signals a living, breathing server economy. Real player rankings verified those observations. 강남가라오케